The approval of the Roundup ingredient follows an extensive debate amidst conflicting evidence over the health effects of the world’s most popular weed killer. After a year teaching an algorithm to ...
8d
Pharmaceutical Technology on MSNEC approves Otsuka and Lundbeck’s Rxulti for schizophreniaThe decision was supported by a randomised, six-week, placebo-controlled trial involving 316 adolescent subjects.
OKX secured a pre-authorization status under the MiCA framework, becoming the first virtual financial assets exchange to ...
18d
Pharmaceutical Technology on MSNEC approves Bavarian Nordic’s chikungunya vaccine marketingThe European Commission (EC) has authorised the marketing of Bavarian Nordic's Vimkunya - the first chikungunya vaccine approved in Europe for individuals as young as 12 years old. Vimkunya is a virus ...
The European Commission (EC) set out plans to make €100 billion available to support eco-friendly manufacturing of technology, as part of its Clean Industrial Deal (CID) which aims to cut red tape and ...
12d
GlobalData on MSNEC approves BMS’ Opdivo and Yervoy combo for HCCThe European Commission (EC) has granted approval for Bristol Myers Squibb’s (BMS) Opdivo (nivolumab) in combination with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results